# Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

> **NCT00000344** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 40 (—)

## Conditions studied

- Opioid-Related Disorders

## Interventions

- **DRUG:** Buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT00000344
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2000-08
- **Target enrollment:** 40 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000344, "Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*